搜索页_+Infliximab

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：1,982条，耗时：小于0.01 秒

1.Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines

作者：Haggai Bar-Yoseph^&lowast ; ; ^a ; ^{haggaiby@gmail.com} ; Matti Waterman^&Dagger ; ; ^a ; Ronit Almog^§ ; ; Thomas Billiet^‖ ; Sé ; verine Vermeire^‖ ; Bella Ungar^¶ ; ; Henit Yanai^# ; Iris Dotan^# ; Shomron Ben-Horin^¶ ; ; Yehuda Chowers^&Dagger ;

关键词：Crohn's Disease ; Infliximab ; Thiopurines ; Antidrug Antibodies

刊名：Clinical Gastroenterology and Hepatology

出版年：2017

2.Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis

作者：Anne-Claire Frin^a ; ¹ ; Jé ; rô ; me Filippi^a ; ¹ ; Gilles Boschetti^b ; Bernard Flourie^b ; Jocelyne Drai^c ; Patricia Ferrari^d ; Xavier Hebuterne^a ; Sté ; phane Nancey^b ; ^{stephane.nancey@chu-lyon.fr}

关键词：Fecal markers ; Response to infliximab ; Ulcerative colitis

刊名：Digestive and Liver Disease

出版年：2017

3.One-month stability study of a biosimilar of infliximab (Remsima^®) after dilution and storage at 4 °C and 25 °C

作者：V. Vieillard ; ^{victoire.vieillard@aphp.fr} ; A. Astier ; C. Sauzay ; M. Paul

关键词：Monocolonal antibody ; Biosimilar ; Physical stabililty ; Chemical stability ; &ldquo ; In-use&rdquo ; conditions

刊名：Annales Pharmaceutiques Françaises

出版年：2017

4.Enfermedad inflamatoria intestinal como efecto paradójico del tratamiento con anti-TNF-α

作者：Ainara Iriarte^a ; ^{airiartr@gmail.com} ; Celia Zaera^b ; Javier Bachiller-Corral^c ; Antonio Ló ; pez-Sanromá ; n^b

关键词：Enfermedad inflamatoria intestinal ; Efectos paradó ; jicos ; Anti-TNF-α ; Infliximab ; Etanercept ; Adalimumab

刊名：Gastroenterología y Hepatología

出版年：2017

5.Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease

作者：Cristina Guiotto^a ; Marco Daperno^b ; ^{mdaperno@teletu.it" class="auth_mail" title="E-mail the corresponding author} ; Francesco Frigerio^b ; Margherita Vizzini^a ; Roberta Cerruti^a ; Elena Ercole^b ; Maurizio Cosimato^b ; Alessandro Lavagna^b ; Laura Germano^a ; Marco Migliardi^a ; Rodolfo Rocca^b

关键词：Inflammatory bowel disease ; Infliximab ; Therapeutic drug monitoring

刊名：Digestive and Liver Disease

出版年：2016

6.Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease

作者：Karin Malí ; čková ; ^a ; ^{karin.malickova@vfn.cz" class="auth_mail" title="E-mail the corresponding author} ; Dana Ďuricová ; ^b ; ^c ; Martin Bortlí ; k^b ; ^d ; Miroslav Hind&rsquo ; o&scaron ; ^a ; Naděžda Machková ; ^b ; Veronika Hrubá ; ^b ; Martin Luká ; &scaron ; ^b ; Tomá ; &scaron ; Zima^a ; Milan Luká ; &scaron ; ^a ; ^b

关键词：Infliximab ; Biosimilar ; CT-P13 ; Inflammatory bowel disease ; Enzyme-linked immunosorbent assay

刊名：Biologicals

出版年：2016

7.Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn’s disease patients treated with infliximab

作者：B. Herná ; ndez-Breijo^a ; M. Chaparro^b ; D. Cano-Martí ; nez^a ; I. Guerra^c ; M. Iborra^d ; J.L. Cabriada^e ; L. Bujanda^f ; C. Taxonera^g ; V. Garcí ; a-Sá ; nchez^h ; I. Marí ; n-Jimé ; nezⁱ ; M. Barreiro-de Acosta^j ; I. Vera^k ; M.D. Martí ; n-Arranz^l ; F. Mesonero^m ; L. Sempereⁿ ; F. Gomolló ; n^o ; J. Hinojosa^p ; J.P. Gisbert^b ; L.G. Guijarro^a ; ^{luis.gonzalez@uah.es} ; on behalf of the PREDICROHN study group from GETECCU

关键词：Infliximab ; Anti-drug antibodies ; Crohn&rsquo ; s disease ; HMSA

刊名：Biochemical Pharmacology

出版年：2016

8.Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn’s disease. A study performed using the Lémann Index

作者：Giorgia Bodini^a ; ^{bodini.giorgia@gmail.com} ; Edoardo G. Giannini^a ; Costanza De Maria^a ; Pietro Dulbecco^a ; Manuele Furnari^a ; Elisa Marabotto^a ; Vincenzo Savarino^a ; Edoardo Savarino^b

关键词：Adalimumab ; Follow-up ; Inflammatory bowel disease ; Infliximab ; Treatment

刊名：Digestive and Liver Disease

出版年：2017

9.Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience

作者：Gabrielle Brown ; MD ; MS^a ; Eva Wang ; MD^a ; Argentina Leon ; MD^a ; Monica Huynh ; DO^a ; Mackenzie Wehner ; MD^a ; Rebecca Matro ; MD^b ; Eleni Linos ; MD ; PhD^a ; Wilson Liao ; MD^a ; Anna Haemel ; MD^a ; ^{Anna.Haemel@ucsf.edu}

关键词：adalimumab ; adverse event ; certolizumab ; etanercept ; golimumab ; infliximab ; medication side effect ; psoriasis ; tumor necrosis factor-α-induced psoriasis ; tumor necrosis factor-α inhibitor

刊名：Journal of the American Academy of Dermatology

出版年：2017

10.Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa

作者：Henri Montaudié ; MD^a ; Barbara Seitz-Polski ; MD ; PhD^b ; Aurore Cornille ; MSc^b ; Sylvia Benzaken ; MD^b ; Jean-Philippe Lacour ; MD^a ; Thierry Passeron ; MD ; PhD^a ; ^c ; ^{thierry.passeron@unice.fr}

刊名：Journal of the American Academy of Dermatology

出版年：2017

按检索点细分(1982)

题名(1165)

作者(2)

关键词(555)

文摘(1016)

按出版年细分(1982)

2027年及以后(74)

2017年(18)

2016年(151)

2015年(43)

2014年(3)

2013年(192)

2012年(216)

2011年(128)

2010年(151)

2009年(206)

2008年(178)

2007年(135)

2006年(101)

2005年(113)

2004年(100)

2003年(45)

2002年(49)

2001年(25)

2000年(25)

2000年及以前(29)